These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 12416786)

  • 21. [The status of coxibs].
    Künzel D
    Krankenpfl J; 2004; 42(7-10):237. PubMed ID: 15675400
    [No Abstract]   [Full Text] [Related]  

  • 22. [Selective Cox-2 inhibitor in osteoarthritis and rheumatoid arthritis. No increased risk for the heart].
    MMW Fortschr Med; 2003 Mar; 145(11):60. PubMed ID: 12688204
    [No Abstract]   [Full Text] [Related]  

  • 23. Coxibs and cardiovascular risk.
    Allen MJ; McLean-Veysey P; Fleming I
    CMAJ; 2005 Oct; 173(8):853. PubMed ID: 16217098
    [No Abstract]   [Full Text] [Related]  

  • 24. Efficacy and safety of aceclofenac in the treatment of osteoarthritis: a randomized double-blind comparative clinical trial versus diclofenac - an Indian experience.
    Pareek A; Chandanwale AS; Oak J; Jain UK; Kapoor S
    Curr Med Res Opin; 2006 May; 22(5):977-88. PubMed ID: 16709320
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative cardiovascular safety of traditional nonsteroidal anti-inflammatory drugs.
    Maillard M; Burnier M
    Expert Opin Drug Saf; 2006 Jan; 5(1):83-94. PubMed ID: 16370958
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Geriatric pharmacology: osteoarthritis.
    Cuddy ML
    J Pract Nurs; 2005; 55(1):6-15; quiz 16-7. PubMed ID: 15918532
    [No Abstract]   [Full Text] [Related]  

  • 27. Tempering the enthusiasm for COX-2 inhibitors.
    Nuovo J
    Am Fam Physician; 2000 Jun; 61(12):3560, 3563. PubMed ID: 10892630
    [No Abstract]   [Full Text] [Related]  

  • 28. Osteoarthritis therapy--are there still unmet needs?
    Laufer S
    Rheumatology (Oxford); 2004 Feb; 43 Suppl 1():i9-15. PubMed ID: 14752170
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The COX 2 selective inhibitors: what the newspapers have not told you.
    Simon LS
    Bull NYU Hosp Jt Dis; 2007; 65(3):229-41. PubMed ID: 17922675
    [No Abstract]   [Full Text] [Related]  

  • 30. Efficacy and safety of diclofenac-cholestyramine and celecoxib in osteoarthritis.
    Suárez-Otero R; Robles-San Román M; Jaimes-Hernández J; Oropeza-De La Madrid E; Medina-Peñaloza RM; Rosas-Ramos R; Castañeda-Hernández G
    Proc West Pharmacol Soc; 2002; 45():26-8. PubMed ID: 12434517
    [No Abstract]   [Full Text] [Related]  

  • 31. Newer and safer options for osteoarthritis.
    Miller CA
    Geriatr Nurs; 2001; 22(3):165-6. PubMed ID: 11410770
    [No Abstract]   [Full Text] [Related]  

  • 32. Standard NSAIDs vs. COX-2 inhibitors.
    Johns Hopkins Med Lett Health After 50; 2002 Jan; 13(11):3. PubMed ID: 14727601
    [No Abstract]   [Full Text] [Related]  

  • 33. A cross-sectional retrospective assessment of anti-arthritic drugs in patients with arthritis in Korea.
    Lee MC; Lee S; Suh DC; Kim J; Kong SX;
    Curr Med Res Opin; 2003; 19(7):597-602. PubMed ID: 14606981
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The choreography of cyclooxygenases in the kidney.
    FitzGerald GA
    J Clin Invest; 2002 Jul; 110(1):33-4. PubMed ID: 12093885
    [No Abstract]   [Full Text] [Related]  

  • 35. Celecoxib versus naproxen and diclofenac in osteoarthritis patients: SUCCESS-I Study.
    Singh G; Fort JG; Goldstein JL; Levy RA; Hanrahan PS; Bello AE; Andrade-Ortega L; Wallemark C; Agrawal NM; Eisen GM; Stenson WF; Triadafilopoulos G;
    Am J Med; 2006 Mar; 119(3):255-66. PubMed ID: 16490472
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Experience of rofecoxib in patients with osteoarthritis previously treated with traditional non-steroidal anti-inflammatory drugs in Spain: results of phase 2 of the VICOXX study.
    Arboleya LR; de la Figuera E; Soledad García M; Aragón B;
    Curr Med Res Opin; 2003; 19(4):288-97. PubMed ID: 12841921
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Appropriateness of NSAID and Coxib prescribing for patients with osteoarthritis by primary care physicians in Ontario: results from the CANOAR study.
    Sebaldt RJ; Petrie A; Goldsmith CH; Marentette MA
    Am J Manag Care; 2004 Nov; 10(11 Pt 1):742-50. PubMed ID: 15623264
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cost of heart failure among hypertensive users of nonspecific NSAIDs and COX-2-specific inhibitors.
    Zhao SZ; Burke TA; Whelton A; von Allmen H; Henderson SC
    Am J Manag Care; 2002 Oct; 8(15 Suppl):S414-27. PubMed ID: 12416791
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anti-inflammatory agents and renal function.
    Brater DC
    Semin Arthritis Rheum; 2002 Dec; 32(3 Suppl 1):33-42. PubMed ID: 12528072
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Defining the problem of treating the patient with hypertension and arthritis pain.
    White WB
    Am J Med; 2009 May; 122(5 Suppl):S3-9. PubMed ID: 19393824
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.